300009.SZ
Anhui Anke Biotechnology (Group) Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 7.85
+0.38%Year over year
Reported trailing growth
- Revenue
- +2.0%
- EBITDA
- —
- EBIT
- -1.3%
- EPS
- +0.8%
- Free cash flow
- +5.8%
- Operating cash flow
- +11.4%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +4.3%
- EBITDA
- +1.1%
- EBIT
- -0.2%
- Net income
- +1.5%
- EPS
- +0.8%
- Free cash flow
- +48.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026